Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.89
Delayed Data
As of 9:43am ET
 +0.02 / +1.07%
Today’s Change
1.71
Today|||52-Week Range
5.30
+2.72%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +5.82% increase from the last price of 1.89.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Protalix Biotherapeutics Inc. This rating has held steady since March, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$3.7M
Reporting Date
Dec 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.57%
 
 
 
 
 
 
Growthannually 91.67%
 
 
 
 
 
 

Sales

Growthquarterly 37.91%
 
 
 
 
 
 
Growthannually 170.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account